| Dr Megan Rae Tucker, OD | |
|
1200 S Air Depot Blvd Ste A, Midwest City, OK 73110-4848 | |
| (405) 494-8100 | |
| Not Available |
| Full Name | Dr Megan Rae Tucker |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 1200 S Air Depot Blvd Ste A, Midwest City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134857279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3205 (Oklahoma) | Primary |
| Provider Name | Cherokee Nation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
In a post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, the foundation's Gary Darmstadt, Wendy Prosser, and Andrew Serazin discuss the finalists of the Saving Lives at Birth initiative, who came together at last week's DevelopmentXChange in Seattle.
Small and stand-alone nonprofit hospitals are facing mounting pressure from weak operating margins and lower patient volumes, according to a report from Standard & Poor's Rating Services. Meanwhile, hospitals cope with the changing health care landscape by exploring ways to help low-income consumers pay their Obamacare premiums and offering no-interest payment plans for those with high-deductible insurance policies.
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has accepted Labopharm's response regarding its novel formulation of the antidepressant trazodone as complete and designated it as a Class 2 resubmission. The FDA has assigned Labopharm a new Prescription Drug User Fee Act (PDUFA) action date of February 11, 2010.
Tenex Health today announces FDA 510(k) clearance of the TX1 Tissue Removal System. This portable, self-contained system offers precise soft tissue removal for tendons and other soft tissues with intended use in the elbow, knee, ankle, foot, and shoulder.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Megan Rae Tucker, OD 3730 E Mountain Rd, Bartlesville, OK 74003-6928 Ph: (918) 886-0312 | Dr Megan Rae Tucker, OD 1200 S Air Depot Blvd Ste A, Midwest City, OK 73110-4848 Ph: (405) 494-8100 |
News Archive
In a post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, the foundation's Gary Darmstadt, Wendy Prosser, and Andrew Serazin discuss the finalists of the Saving Lives at Birth initiative, who came together at last week's DevelopmentXChange in Seattle.
Small and stand-alone nonprofit hospitals are facing mounting pressure from weak operating margins and lower patient volumes, according to a report from Standard & Poor's Rating Services. Meanwhile, hospitals cope with the changing health care landscape by exploring ways to help low-income consumers pay their Obamacare premiums and offering no-interest payment plans for those with high-deductible insurance policies.
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has accepted Labopharm's response regarding its novel formulation of the antidepressant trazodone as complete and designated it as a Class 2 resubmission. The FDA has assigned Labopharm a new Prescription Drug User Fee Act (PDUFA) action date of February 11, 2010.
Tenex Health today announces FDA 510(k) clearance of the TX1 Tissue Removal System. This portable, self-contained system offers precise soft tissue removal for tendons and other soft tissues with intended use in the elbow, knee, ankle, foot, and shoulder.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.
› Verified 7 days ago
Dr. Kathleen Yang, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8121 National Ave, Suite 409, Midwest City, OK 73110 Phone: 405-737-8935 Fax: 405-737-8934 | |
Midwest City Eye Care Associates Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 8121 National Ave, Suite 409, Midwest City, OK 73110 Phone: 405-737-8935 Fax: 405-737-8934 | |
Bob Baldwin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6912 E Reno Ave, Suite 101, Midwest City, OK 73110 Phone: 405-732-2277 Fax: 405-737-4776 | |
Sawyer Lee, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2008 S Post Rd, Midwest City, OK 73130 Phone: 405-732-2277 Fax: 407-737-4776 | |
Dr. Elizabeth Mccrackin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2008 S Post Rd, Midwest City, OK 73130 Phone: 405-732-2277 Fax: 405-737-4776 | |
Midwest Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 1029 S Post Rd, Midwest City, OK 73130 Phone: 405-737-0713 Fax: 405-732-2225 |